{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T21:17:05Z","timestamp":1764364625169,"version":"3.41.2"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Subclinical thyrotoxicosis (SCT) is defined by low or undetectable thyroid-stimulating hormones and normal thyroid hormones. The treatment of SCT is uncertain despite being associated with increased cardiovascular risk (CVR) and mortality. Circulating endothelial progenitor cells (cEPCs) and circulating angiogenic cells (CACs) have been found to be reduced in conditions with CVR. We aimed to evaluate whether endothelial function and cEPC and CAC counts were reduced in SCT and to study the <jats:italic>in vitro<\/jats:italic> effect of triiodothyronine (T3) on proangiogenic cell (PAC) function from young healthy controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>cEPCs (quantified by flow cytometry, 20 SCT\/20 controls), CACs following <jats:italic>in vitro<\/jats:italic> cultures (15 SCT\/14 controls), paracrine function of CACs, endothelial function by flow-mediated dilation (FMD, 9 SCT\/9 controls), and the effect of T3 on apoptosis and endothelial nitric oxide synthase (<jats:italic>eNOS<\/jats:italic>) expression in PACs were studied.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p><jats:italic>p<\/jats:italic>\u00a0&amp;lt;\u00a00.001, CD133<jats:sup>+<\/jats:sup>\/VEGFR-2<jats:sup>+<\/jats:sup> 0.4 (0.0\u20130.7) vs. 0.6 (0.0\u20134.6), <jats:italic>p<\/jats:italic>\u00a0=\u00a00.009, CD34<jats:sup>+<\/jats:sup>\/VEGFR-2<jats:sup>+<\/jats:sup> 0.3 (0.0\u20131.0) vs. 0.7 (0.1\u20134.9), <jats:italic>p<\/jats:italic>\u00a0=\u00a00.002; while CAC count was similar. SCT predicted a lower cEPC count after adjustment for conventional CVR factors. FMD was lower in SCT subjects versus controls (% mean \u00b1 SD, 2.7 \u00b1 2.3 vs. 6.1 \u00b1 2.3, <jats:italic>p<\/jats:italic>\u00a0=\u00a00.005). <jats:italic>In vitro<\/jats:italic> studies showed T3 increased early apoptosis and reduced <jats:italic>eNOS<\/jats:italic> expression in PACs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In conclusion, SCT is associated with reduced cEPC count and FMD, confirming increased CVR in SCT. Future outcome trials are required to examine if treatment of this subclinical hyperactive state improves cardiovascular outcome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical Trial Registration<\/jats:title><jats:p><jats:uri>http:\/\/www.controlled-trials.com\/isrctn\/<\/jats:uri>, identifier ISRCTN70334066.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.894093","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T04:36:51Z","timestamp":1658119011000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Subclinical Thyrotoxicosis and Cardiovascular Risk: Assessment of Circulating Endothelial Progenitor Cells, Proangiogenic Cells, and Endothelial Function"],"prefix":"10.3389","volume":"13","author":[{"given":"Jason","family":"Phowira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherin","family":"Bakhashab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Doddaballapur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanta U.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1161\/hh1301.093953","article-title":"Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease","volume":"89","author":"Vasa","year":"2001","journal-title":"Circ Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1056\/NEJMoa043814","article-title":"Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes","volume":"353","author":"Werner","year":"2005","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1056\/NEJMoa022287","article-title":"Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk","volume":"348","author":"Hill","year":"2003","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.694778","article-title":"Identification of a Novel Role of T Cells in Postnatal Vasculogenesis: Characterization of Endothelial Progenitor Cell Colonies","volume":"116","author":"Hur","year":"2007","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.24423","article-title":"Circulating and Tissue Resident Endothelial Progenitor Cells","volume":"229","author":"Basile","year":"2014","journal-title":"J Cell Physiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12933-016-0413-6","article-title":"Metformin Improves Circulating Endothelial Cells and Endothelial Progenitor Cells in Type 1 Diabetes: MERIT Study","volume":"15","author":"Ahmed","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2007.11.002","article-title":"Circulating Endothelial Microparticles Correlate Inversely With Endothelial Function in Patients With Ischemic Left Ventricular Dysfunction","volume":"14","author":"Bulut","year":"2008","journal-title":"J Card Fail"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1401-0","article-title":"Circulating Endothelial Progenitor Cells, Endothelial Function, Carotid Intima-Media Thickness and Circulating Markers of Endothelial Dysfunction in People With Type 1 Diabetes Without Macrovascular Disease or Microalbuminuria","volume":"52","author":"Sibal","year":"2009","journal-title":"Diabetologia"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.02.049","article-title":"Exercise Acutely Increases Circulating Endothelial Progenitor Cells and Monocyte-\/Macrophage-Derived Angiogenic Cells","volume":"43","author":"Rehman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1421","article-title":"Endothelial Progenitor Cells in Subclinical Hypothyroidism: The Effect of Thyroid Hormone Replacement Therapy","volume":"95","author":"Shakoor","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1161\/hc2401.092816","article-title":"Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease","volume":"103","author":"Vasa","year":"2001","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2006.07.029","article-title":"Pioglitazone Increases the Numbers and Improves the Functional Capacity of Endothelial Progenitor Cells in Patients With Diabetes Mellitus","volume":"152","author":"Wang","year":"2006","journal-title":"Am Heart J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T(4), and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.9.1033","article-title":"Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults","volume":"295","author":"Cappola","year":"2006","journal-title":"JAMA"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06067-6","article-title":"Prediction of All-Cause and Cardiovascular Mortality in Elderly People From One Low Serum Thyrotropin Result: A 10-Year Cohort Study","volume":"358","author":"Parle","year":"2001","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411103311901","article-title":"Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons","volume":"331","author":"Sawin","year":"1994","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.21.2591","article-title":"Thyroid Status, Disability and Cognitive Function, and Survival in Old Age","volume":"292","author":"Gussekloo","year":"2004","journal-title":"JAMA"},{"key":"B18","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1001\/archinternmed.2012.402","article-title":"Subclinical Hyperthyroidism and the Risk of Coronary Heart Disease and Mortality","volume":"172","author":"Collet","year":"2012","journal-title":"Arch Intern Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-2693","article-title":"The Thyroid Epidemiology, Audit, and Research Study (TEARS): Morbidity in Patients With Endogenous Subclinical Hyperthyroidism","volume":"96","author":"Vadiveloo","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.04.034","article-title":"Thyroid Hormone Use, Hyperthyroidism and Mortality in Older Women","volume":"120","author":"Bauer","year":"2007","journal-title":"Am J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1869","article-title":"The Beneficial Effect of L-Thyroxine on Cardiovascular Risk Factors, Endothelial Function, and Quality of Life in Subclinical Hypothyroidism: Randomized, Crossover Trial","volume":"92","author":"Razvi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013790","article-title":"Quantification of Circulating Endothelial Progenitor Cells Using the Modified ISHAGE Protocol","volume":"5","author":"Schmidt-Lucke","year":"2010","journal-title":"PloS One"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404676","article-title":"Working Hypothesis to Redefine Endothelial Progenitor Cells","volume":"21","author":"Prater","year":"2007","journal-title":"Leukemia"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmu073","article-title":"The Influence of Nitroglycerin on the Proliferation of Endothelial Progenitor Cells From Peripheral Blood of Patients With Coronary Artery Disease","volume":"46","author":"Wang","year":"2014","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1530\/EJE-09-0875","article-title":"Clinical Relevance of Thyroid Dysfunction in Human Haematopoiesis: Biochemical and Molecular Studies","volume":"162","author":"Kawa","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2005.07.119","article-title":"Characterization of Endothelial Progenitor Cells","volume":"336","author":"Fadini","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000137877.89448.78","article-title":"Endothelial Progenitor Cells: Characterization and Role in Vascular Biology","volume":"95","author":"Urbich","year":"2004","journal-title":"Circ Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S1050-1738(03)00077-X","article-title":"Endothelial Progenitor Cells: Isolation and Characterization","volume":"13","author":"Hristov","year":"2003","journal-title":"Trends Cardiovasc Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0755","article-title":"VEGFR-3 and CD133 Identify a Population of CD34+ Lymphatic\/Vascular Endothelial Precursor Cells","volume":"101","author":"Salven","year":"2003","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00261.x","article-title":"Risk Factors for Coronary Artery Disease, Circulating Endothelial Progenitor Cells, and the Role of HMG-CoA Reductase Inhibitors","volume":"67","author":"Urbich","year":"2005","journal-title":"Kidney Int"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.11.067","article-title":"Circulating Endothelial Progenitor Cells Are Reduced in Peripheral Vascular Complications of Type 2 Diabetes Mellitus","volume":"45","author":"Fadini","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000133311.25587.DE","article-title":"Circulating CD34-Positive Cells Provide an Index of Cerebrovascular Function","volume":"109","author":"Taguchi","year":"2004","journal-title":"Circulation"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000149944.15406.16","article-title":"Endothelial Progenitor Cells During Cerebrovascular Disease","volume":"36","author":"Ghani","year":"2005","journal-title":"Stroke"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.504340","article-title":"Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events: Proof of Concept for the Clinical Importance of Endogenous Vascular Repair","volume":"111","author":"Schmidt-Lucke","year":"2005","journal-title":"Circulation"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nm948","article-title":"Essential Role of Endothelial Nitric Oxide Synthase for Mobilization of Stem and Progenitor Cells","volume":"9","author":"Aicher","year":"2003","journal-title":"Nat Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/BF03347423","article-title":"Asymmetric Dimethylarginine Levels in Thyroid Diseases","volume":"30","author":"Arikan","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020905","article-title":"Plasma Concentration of Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, is Elevated in Hyperthyroid Patients","volume":"87","author":"Hermenegildo","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2174\/1871530319666190206125545","article-title":"Comparison of Mean Platelet Volume, Platelet Count, Neutrophil\/ Lymphocyte Ratio and Platelet\/Lymphocyte Ratio in the Euthyroid, Overt Hypothyroid and Subclinical Hyperthyroid Phases of Papillary Thyroid Carcinoma","volume":"19","author":"Kutluturk","year":"2019","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1089\/1050725041692891","article-title":"Evaluation of Endothelial Function in Subclinical Hypothyroidism and Subclinical Hyperthyroidism","volume":"14","author":"Cikim","year":"2004","journal-title":"Thyroid"},{"key":"B40","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1089\/thy.2007.0299","article-title":"Exogenous Subclinical Hyperthyroidism Impairs Endothelial Function in Nodular Goiter Patients","volume":"18","author":"Yavuz","year":"2008","journal-title":"Thyroid"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.843857","article-title":"Radioactive Iodine for the Treatment of Subclinical Thyrotoxicosis Grade 1 and 2: Outcome of Up to 18-Year Follow Up (Accepted)","volume":"13","author":"Phowira","year":"2022","journal-title":"Front Endocrinol"},{"key":"B42","unstructured":""},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0110","article-title":"Subclinical Thyroid Dysfunction and Mortality: An Estimate of Relative and Absolute Excess All-Cause Mortality Based on Time-to-Event Data From Cohort Studies","volume":"159","author":"Haentjens","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1210\/er.2006-0043","article-title":"The Clinical Significance of Subclinical Thyroid Dysfunction","volume":"29","author":"Biondi","year":"2008","journal-title":"Endocr Rev"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.894093\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T04:36:54Z","timestamp":1658119014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.894093\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":44,"alternative-id":["10.3389\/fendo.2022.894093"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.894093","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"article-number":"894093"}}